A new study suggests that pancreatic exocrine dysfunction develops after initiation of islet cell autoimmunity, suggesting that exocrine dysfunction is related to diabetes disease pathogenesis itself.
There is a need for bridging the disconnect between policies that address underweight and overweight children and adolescents.
Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.
Higher-dose and specialized treatment content designed to help families maintain weight-control behaviors following family-based behavioral weight loss treatment enhances weight outcomes.
Grip strength has clinical utility in identifying people with diabetes at risk for poor health outcomes.
The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.
Researchers assessed whether long-term use of long-acting insulin analogs, compared with the use of neutral protamine Hagedorn insulin, is associated with an increased risk of breast cancer in women with T2D.
Investigators encourage further research on the use of NSAIDs in women with preeclampsia who develop postpartum hypertension.
Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.
A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.
